Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study
about
Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study.Use of antidepressants and the risk of Parkinson's disease: a prospective study.The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.
P2860
Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treatment with antidepressants ...... pharmacoepidemiological study
@ast
Treatment with antidepressants ...... pharmacoepidemiological study
@en
type
label
Treatment with antidepressants ...... pharmacoepidemiological study
@ast
Treatment with antidepressants ...... pharmacoepidemiological study
@en
prefLabel
Treatment with antidepressants ...... pharmacoepidemiological study
@ast
Treatment with antidepressants ...... pharmacoepidemiological study
@en
P2093
P2860
P356
P1476
Treatment with antidepressants ...... pharmacoepidemiological study
@en
P2093
F M Nilsson
M Brandt-Christensen
P K Andersen
P2860
P304
P356
10.1136/JNNP.2005.083345
P407
P577
2006-06-01T00:00:00Z